Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
New Neurons Born among the Dying in Alzheimer’s Hippocampus?
3 December 2003. Is the cycle of life—new lives born even as the old die—to be found in the hippocampus of Alzheimer's patients? A study in this week’s online PNAS suggests just this, and poses the question of whether we could spur newly born neurons to replace those that are degenerating.

At the Buck Institute for Aging Research in Novato, California, David Greenberg, Kunlin Jin, and their colleagues compared AD and non-AD brain tissue for levels of molecules that are expressed in immature neurons. They found that AD hippocampus contains significantly higher expression of doublecortin, polysialylated nerve cell adhesion molecule (PSA-NCAM), neurogenic differentiation factor (NeuroD), and TUC-4.

In particular, they found that expression of doublecortin and TUC-4 was associated with neurons in the proliferative zone of the dentate gyrus and in the ultimate home of these cells—the granule cell layer—as well as in the CA1 region of Ammon’s horn, a principal site of hippocampal pathology in AD.

"These findings suggest that neurogenesis is increased in AD hippocampus, where it may give rise to cells that replace neurons lost in the disease, and that stimulating hippocampal neurogenesis might provide a new treatment strategy," write the authors.

Addressing possible objections, the authors note that it is unlikely they were simply observing the effects of brain atrophy. For example, actin expression was unchanged, whereas levels of the immature neuronal markers varied with disease severity and anatomical location, among other factors.

Another concern is that transgenic models of AD have shown the opposite, namely, a diminution of neurogenesis. Noting that these models all fail to recapitulate AD fully, the authors suggest it will be interesting to test whether more recent models, such as the APP/tau mice, might show increased neurogenesis.—Hakon Heimer.

Reference:
Jin K, Peel AL, Mao XO, Lin X, Cottrell B, Henshall DC, Greenberg DA. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A. 2003 Dec 5 [Epub ahead of print] Abstract

 
Comments on News and Primary Papers
  Comment by:  Kiminobu Sugaya
Submitted 9 December 2003  |  Permalink Posted 9 December 2003

For stem cell researchers, this is an encouraging report which indicates neurogenesis in the Alzheimer's disease (AD) patient's brain. If this finding is true, just increasing the stem cell population in the patient’s brain might help to regenerate dying neurons in AD. Since we have a small-molecule compound that increases endogenous stem cell population about sixfold in 27-month-aged rats by peripheral injection, we may be able to develop an application for this drug in AD treatment.

However, as the author pointed out, APP- or PS-mutant transgenic mice show impaired rather than increased neurogenesis. Such a conflict may come from the different patient populations, namely, sporadic and familial AD, meaning if they analyze familial AD they might find different results. Furthermore, their best clear finding is an increased level of PSA-NCAM in severe AD cases, and PSA-NCAM is not necessarily a marker for neuronal progenitors because it is also expressed in reactive astrocytes (Nomura...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad